|
Symbol
|
P322TQ | PMWLTQ | WEVLTQ | LTARCH | WXNLTQ | EOJRCH | XRYLTQ | RMABXV | YOTLTQ | RMBVJV | RMBWDV | RMAVSV | Z0972Z | Z0974Z | Z0973Z | BTJBKB | ZPRLTQ | OCGRCH | HZJEFG | BZFBKB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible | Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Geberit AG / Givaudan / Holcim/Amrize Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche AG / Swatch Group I / Swiss RE AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Geberit AG / Roche GS / Sonova Hldg. AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Lonza Group N / Roche GS / Sika AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
23.12.2025 | 09.02.2026 | 31.03.2028 | 24.09.2027 | 30.06.2028 | 14.01.2026 | 22.09.2028 | 12.10.2026 | 24.11.2027 | 22.12.2025 | 27.07.2026 | 23.02.2026 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 02.11.2026 | 12.07.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
66,90 | 24,49 | 49,63 | 261,75 | 58,95 | 287,84 | 59,97 | 65,70 | 63,075 | 388,94 | 282,20 | 61,91 | 22,9033 | 22,9279 | 22,9033 | 43,685 | 42,50 | 275,714 | 152,49 | 346,12 |
| rendement max. p.a. | 70,95% | - | 4,91% | - | 6,24% | - | 9,99% | 8,89% | 5,77% | -0,44% | 4,63% | 86,07% | 4,09% | 7,95% | 6,15% | 3,76% | - | - | - | 14,70% |
| Demande | 99,23 | - | 100,80 | - | 94,86 | 100,60 | - | 96,20 | 96,40 | 99,40 | 99,80 | 79,00 | 106,20 | 108,68 | 107,65 | - | - | - | 84,80 | 89,36 |
| Offre | 100,03 | - | 101,61 | - | 95,66 | 101,41 | - | 97,00 | 97,20 | 100,20 | 100,80 | 86,00 | 106,95 | 109,43 | 108,40 | - | - | - | - | 90,16 |